Planned maintenance may cause outages to the Department of Health and Aged Care’s network from 5:15 pm AEDT on 30 November to 10:00 pm AEDT on 1 December 2024. Access to TGA databases such as TBS Portal, ARTG and DAEN may be affected. We apologise for any inconvenience.
GARDASIL 9 Human Papillomavirus 9-valent Vaccine, Recombinant, 30, 40, 60, 40, 20, 20, 20, 20, 20 micrograms/0.5mL, suspension for injection, syringe (224092)
ARTG ID 224092
ARTG Name
GARDASIL 9 Human Papillomavirus 9-valent Vaccine, Recombinant, 30, 40, 60, 40, 20, 20, 20, 20, 20 micrograms/0.5mL, suspension for injection, syringe
Product name
GARDASIL 9 Human Papillomavirus 9-valent Vaccine, Recombinant, 30, 40, 60, 40, 20, 20, 20, 20, 20 micrograms/0.5mL, suspension for injection, syringe
ARTG Date
Registration Type
Medicine
Therapeutic good type
Medicine
Ingredients
HPV Type 11 L1 Protein
HPV Type 16 L1 Protein
HPV Type 18 L1 Protein
HPV Type 31 L1 Protein
HPV Type 33 L1 Protein
HPV Type 45 L1 Protein
HPV Type 52 L1 Protein
HPV Type 58 L1 Protein
HPV Type 6 L1 Protein
Licence category
RE
Licence status
A
Summary
Product information
Consumer medicine information